Jennifer Alkire, PharmD, Senior Associate, Value & Access, attended AMCP 2024 and brings back these insights.
Updates
The 2024 America’s Best Employers for Diversity rankings resulted from surveying 170,000 US employees
Strategic collaboration follows RTI’s equity investment in advanced tech-enabled research services
When causal inference is applied to pharmacoepidemiology, researchers can estimate which treatments are helpful or harmful.
Institute commits additional $9 million to internal sustainability investments to reduce GHG emissions
Viewers can explore community-level risk of inequities in life expectancy, cancer mortality, drug overdoses and more
Simmons will drive ambitious strategic growth to expand our ability to serve our clients’ needs, enhance our solution offerings, and increase our impact on patient well-being.
Gather information on long-term treatment effects by integrating data from existing studies into a pooled database for analysis.
The rankings acknowledge RTI as a family-friendly workplace in addition to a previous award as one of America’s Greatest Workplaces overall this year
For the 6th year in a row, RTI International (RTI Health Solutions' parent company) has earned the 2023 Military Friendly® Employer designation.
Biomedical, pharmaceutical, and healthcare entities are recognizing their crucial role in addressing health disparities.
Regulatory considerations for both preapproval and postapproval studies. Highlighting early engagement with the FDA at the study design stage.
Research must recognize and explore the multiple drivers of people’s healthcare experiences and outcomes to address inequity.
Article contributed by Naoko Ronquest (she/her), PhD, Executive Director, US HTA Strategy and Early Modeling
The award recognizes RTI’s commitment to providing a positive work environment and creating a culture of belonging
Guideline-Based Treatment Offers Greater Survival for Older Patients with Metastatic Breast Cancer
Medullary thyroid cancer (MTC) is a rare cancer, generally diagnosed at early stages of the disease when prognosis is favorable. Mutations in the RET gene are involved in the development of the cancer and are common in patients with MTC.
Meningococcal disease is caused by the bacterium Neisseria meningitidis and can have serious, life-threatening outcomes. Two types of vaccines are recommended for adolescents and young adults in the United States (US) to protect against meningococcal serotypes ACWY (MenACWY) and B (MenB).
Cigna has selected nonprofit research institute RTI International, parent company of RTI Health Solutions, as a recipient of their silver level Healthy Workforce Designation for demonstrating a strong commitment to improving the health and well-being of its employees through a workplace wellness program.
Acromegaly Symptom Diary Acromegaly is a rare but serious condition caused by pituitary tumors that result in overabundance of growth hormone and insulin-like growth factor-1. This hormonal excess results in tissue growth, including changes to facial features.
Non-small cell lung cancer (NSCLC) is an aggressive disease, with poor prognosis and a high likelihood of brain metastases. Overall survival rates for patients with NSCLC with brain metastases are low.
Traumatic brain injury (TBI) is an alteration in brain function caused by an external force. TBI of so-called mild severity (mTBI) represents 70-90% of cases and is a frequent cause of emergency department visits.
A group of RTI Health Solutions researchers was recently recognized by the wider RTI organization for their contributions to a body of research.
Research coauthored by RTI Health Solutions researchers will be presented at the 2023 Respiratory Synctial Virus Foundation.
Dr. Stephanie Earnshaw, PhD, Senior Vice President, Health Economics at RTI Health Solutions, named a North Carolina State University (NCSU) Distinguished Alumnus, Class of 2022.